Update
Novo Nordisk pushes into Russia with new insulin manufacturing facility
Novo Nordisk has opened a new manufacturing facility in Russia for the formulation and filling of insulin as a diabetes treatment.
Archives for April 12, 2015
International convergence: Australia’s TGA proposes to adopt 10 EMA guidelines
In a sign that pharmaceutical regulators are merging their regulations further, Australia’s TGA (Therapeutic Goods Administration) is seeking to adopt 10 EMA (European Medicines Agency) guidelines on quality, biologics, clinical efficacy, safety, and more.
API quality concerns prompt fines and drug recall orders in Taiwan
Thirteen Taiwanese drugmakers have been fined and ordered to recall products by regulators concerned the APIs they contain are food rather than pharma grade.
Eisai inks R&D Genomics data deal; cuts 25% US jobs
Eisai has inked a deal with a genome analytics firm to aid drug discovery days after announcing it would be cutting 25% of its in-house US workforce.
Parexel beefs up academic offerings with three new partnerships
Waltham, Massachusetts-based CRO Parexel has launched three new academic programs in Germany, Japan and the US, designed to prepare students for careers in the biopharma industry.
CRO Clinipace expands Euro footprint with acquisition of Accovion
With an eye for a stronger presence in Europe, CRO Clinipace has merged with Accovion, Frankfurt, Germany-based full-service CRO.
What links gin, 1960s pop balladeer Donovan and Molecular Profiles?
Molecular Profiles has changed its name to Juniper Pharma Services in a move designed to facilitate further expansion in the US.
Almac to relocate protein business to up capacity and add new services
Almac will transfer its custom peptide manufacturing business to a site at the Edinburgh Technopole business park in Scotland’s capital in a £3.5m move designed to expand capacity.